Generation Bio
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
KERR DOUGLAS officer: CHIEF MEDICAL OFFICER
 Common Stock 11,267 $17.04 $191,990
Option
KERR DOUGLAS officer: CHIEF MEDICAL OFFICER
 Common Stock 11,267 $4.59 $51,716
Option
KERR DOUGLAS officer: CHIEF MEDICAL OFFICER
 Stock Option (right to buy) 11,267 N/A N/A
Sale
ZIMMERMANN TRACY officer: CHIEF DEVELOPMENT OFFI..
 Common Stock 2,500 $33.05 $82,625
Option
ZIMMERMANN TRACY officer: CHIEF DEVELOPMENT OFFI..
 Common Stock 2,500 N/A N/A
Option
ZIMMERMANN TRACY officer: CHIEF DEVELOPMENT OFFI..
 Stock Option (right to buy) 2,500 $33.05 $82,625
Option
ANGELINO MARK D. officer: CHIEF OPERATING OFFICER
 Common Stock 7,500 $4.59 $34,425
Sale
ANGELINO MARK D. officer: CHIEF OPERATING OFFICER
 Common Stock 7,500 $8.53 $63,975
Option
ANGELINO MARK D. officer: CHIEF OPERATING OFFICER
 Stock Option (right to buy) 7,500 N/A N/A
Sale
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Common Stock 5,630 $15.56 $87,575
Option
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Stock Option (right to buy) 5,630 N/A N/A
Sale
ZIMMERMANN TRACY officer: CHIEF DEVELOPMENT OFFI..
 Common Stock 2,500 N/A N/A
Option
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Common Stock 5,630 $0.6 $3,378
Option
ZIMMERMANN TRACY officer: CHIEF DEVELOPMENT OFFI..
 Stock Option (right to buy) 2,500 N/A N/A
Option
ZIMMERMANN TRACY officer: CHIEF DEVELOPMENT OFFI..
 Common Stock 2,500 $4.59 $11,475
Option
KERR DOUGLAS officer: CHIEF MEDICAL OFFICER
 Stock Option (right to buy) 11,267 $4.59 $51,716
Option
KERR DOUGLAS officer: CHIEF MEDICAL OFFICER
 Common Stock 11,267 $4.59 $51,716
Sale
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Common Stock 14,820 $27.99 $414,812
Sale
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Common Stock 14,820 $18.4 $272,688
Option
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Stock Option (right to buy) 14,820 $0.6 $8,892
Sale
KERR DOUGLAS officer: CHIEF MEDICAL OFFICER
 Common Stock 11,267 $18.95 $213,510
Purchase
ROWLAND CHARLES A JR director
 Common Stock 20,408 $24.5 $499,996
Option
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Common Stock 14,820 $0.6 $8,892
Purchase
NICHOLSON DONALD WILLIAM director
 Common Stock 4,081 N/A N/A
Sale
ANGELINO MARK D. officer: CHIEF OPERATING OFFICER
 Common Stock 5,301 N/A N/A
Option
ANGELINO MARK D. officer: CHIEF OPERATING OFFICER
 Common Stock 5,301 N/A N/A
Option
ANGELINO MARK D. officer: CHIEF OPERATING OFFICER
 Stock Option (right to buy) 5,301 $4.59 $24,332
Option
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Stock Option (right to buy) 10,540 N/A N/A
Sale
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Common Stock 10,540 N/A N/A
Option
STANTON MATTHEW officer: CHIEF SCIENTIFIC OFFICER
 Common Stock 10,540 N/A N/A
Option
ANGELINO MARK D. officer: CHIEF OPERATING OFFICER
 Common Stock 62,560 N/A N/A
Option
ANGELINO MARK D. officer: CHIEF OPERATING OFFICER
 Stock Option (right to buy) 62,560 N/A N/A
Purchase
FLYNN JAMES E 10 percent owner, other: Possib..
 Common Stock 225,000 N/A N/A
Purchase
ZONE HEALTHCARE HOLDINGS, LLC 10 percent owner, other: Member..
 Common Stock 400,000 N/A N/A
Purchase
CASDIN CAPITAL, LLC 10 percent owner
 Common Stock 650,000 N/A N/A
Purchase
SEYBOLD WILLIAM 10 percent owner, other: Member..
 Common Stock 400,000 N/A N/A
Purchase
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P. 10 percent owner
 Common Stock 1,100,000 N/A N/A
Purchase
INVUS PUBLIC EQUITIES, L.P. 10 percent owner
 Common Stock 800,000 N/A N/A
Purchase
ROWLAND CHARLES A JR director
 Common Stock 30,000 N/A N/A

Showing 300 to 339 of 339 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: